Previous studies demonstrated that high SERPINE2 expression was related to worse OS, adverse pathologic features and may serve as a prognostic biomarker for bladder cancer (Li F. et al., 2020; Chuang et al., 2021), which was consistent with our findings. The gene discussed is SERPINE2; the disease is urinary bladder cancer.